International Journal of Clinical Research
International Journal of Clinical Research. 2024; 8: (6) ; 10.12208/j.ijcr.20240205 .
总浏览量: 188
青海红十字医院 青海西宁
*通讯作者： 孙君儒,单位：青海红十字医院 青海西宁；
目的 分析黄褐斑用富血小板血浆联合氨甲环酸治疗的效果。方法 选取我院2021年-2022年接收治疗黄褐斑患者95例，随机将其分为两组，其中对照组采用富血小板血浆治疗，观察组用富血小板血浆联合氨甲环酸治疗，比较皮肤黑度值，不良反应发生情况与治疗总有效率进行比较。结果 观察组患者治疗后的皮肤黑度值均低于对照组，不良反应低于对照组，治疗效率高于对照组（P<0.05）。结论 在黄褐斑的临床治疗中采用富血小板血浆联合氨甲环酸可以有效治疗病情。
Objective Analyze the therapeutic effect of platelet rich plasma combined with tranexamic acid on melasma. Methods 95 patients with melasma who received treatment in our hospital from 2021 to 2022 were selected and randomly divided into two groups. The control group received platelet rich plasma treatment, while the observation group received platelet rich plasma combined with tranexamic acid treatment. The skin blackness value, incidence of adverse reactions, and total effective rate of treatment were compared. Results After treatment, the skin blackness values of the observation group patients were lower than those of the control group, and the adverse reactions were lower than those of the control group. The treatment efficiency was higher than that of the control group (P<0.05). Conclusion The combination of platelet rich plasma and tranexamic acid can effectively treat melasma in clinical treatment.
[1] 魏云,丁高中,朱燕萍，等.氨甲环酸微针导入联合口服中药治疗黄褐斑的临床研究[J].中国中西医结合皮肤性病学杂志,2023,22(3):274-276.
[2] 王言,焦敬,马晓丽，等.不同途径应用氨甲环酸及联合治疗黄褐斑的最新研究进展[J].中国医疗美容,2023,13(1): 46-49.
[3] 王兴,曲燕.左旋维C联合氨甲环酸射频导入治疗黄褐斑的临床研究[J].中国美容医学,2023,32(5):22-26.
[4] 曲靖,何大伟.加味逍遥散联合氨甲环酸局部导入治疗肝郁气滞型黄褐斑的疗效[J].临床合理用药杂志,2023, 16(21): 154-156.
[5] 马晨,寇文冠,柯磊，等.关节镜下应用氨甲环酸联合富血小板血浆注射治疗髋关节撞击综合征的效果[J].河北医科大学学报,2023,44(9):1032-1036.
[6] 项倩彤,崔伟,张慧，等.口服氨甲环酸联合超分子水杨酸换肤治疗黄褐斑的疗效及对血清MDA与E_(2)的影响[J].中国美容医学,2024,33(1):95-98.
[7] 王丽君,洪圆圆,潘明星，等.皮秒激光联合氨甲环酸治疗黄褐斑的临床疗效观察[J].大医生,2023,8(20):19-21.
[8] 于瑞星,刘悦,费文敏，等.聚乳酸微针联合氨甲环酸精华液治疗黄褐斑的临床疗效观察[J].北京化工大学学报（自然科学版）,2023,50(1):72-78.
[9] 王奕,唐莉,段鹃，等.氨甲环酸注射液联合Emax光电协同技术治疗黄褐斑疗效观察[J].临床皮肤科杂志,2023, 52(5):292-295.
[10] 陈荣威,梁国雄.富血小板血浆联合氨甲环酸治疗黄褐斑疗效观察[J].中国皮肤性病学杂志,2021,35(2):148-151.